INVITRO PROTECTION OF ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE BY TETRAHYDROAMINOACRIDINE - COMPARISON WITH PHYSOSTIGMINE

被引:5
作者
GALLI, A
MORI, F
GORI, I
LUCHERINI, M
机构
[1] Department of Preclinical and Clinical Pharmacology, University of Florence, 50134 Firenze
关键词
D O I
10.1016/0006-2952(92)90323-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The protective action of 1,2,3,4-tetrahydro-9-aminoacridine (THA) against the long-lasting inactivation of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) brought about by diisopropylfluorophosphate (DFP) and physostigmine, as well as by neostigmine in the case of AChE only, was evaluated by a dilution technique using Electrophorus electricus AChE and horse serum BuChE as target enzymes. In parallel experiments, the ability of physostigmine itself to protect these enzymes from DFP was evaluated and compared with that of THA. THA pretreatment was seen to prevent in a dose-dependent manner the inhibition of both AChE and BuChE. However, it was appreciably more potent towards AChE than towards BuChE. THA mean EC50 values for protecting AChE against 10, 40 and 100-mu-M DFP were 0.04, 0.16 and 0.45-mu-M, respectively; against 1-mu-M physostigmine the value was 1.8-mu-M and against 1.2-mu-M neostigmine it was 3.0-mu-M. The THA mean EC50 value for protecting BuChE against 3-mu-M physostigmine was 0.55-mu-M and the values for protecting against 3, 10 and 40-mu-M DFP were 1.5, 3 and > 10-mu-M, respectively. The protective action of THA was time independent: recovery of the maximal enzymic activity was immediate upon dilution. Unlike THA, the protective action of physostigmine developed progressively after dilution and was maximal within 3-4 (AChE) or 6-8 hr (BuChE). Under our experimental conditions, 0.3-mu-M physostigmine protected approximately 70% of AChE from 40-mu-M DFP and 5-mu-M physostigmine protected 9 and 47% of BuChE from 40 and 3-mu-M DFP, respectively. The results of this work suggest that THA exerts its protective action by shielding the active site of AChE and BuChE from the attack of the inactivating agents on account of its higher enzymic affinity, whereas the protective action of physostigmine against DFP takes advantage also of the carbamylation of the enzyme. These results are in line with the hypothesis that protection of AChE is the primary mechanism responsible for the antidotal action of THA against organophosphorus poisoning.
引用
收藏
页码:2427 / 2433
页数:7
相关论文
共 30 条
[1]  
Bajgar J, 1984, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, V27, P425
[2]  
BUYUKUYSAL RL, 1989, BRAIN RES, V482, P371
[3]   TETRAHYDROAMINOACRIDINE SELECTIVELY ATTENUATES NMDA RECEPTOR-MEDIATED NEUROTOXICITY [J].
DAVENPORT, CJ ;
MONYER, H ;
CHOI, DW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (01) :73-78
[4]   TACRINE SLOWS THE RATE OF AGING OF SARIN-INHIBITED ACETYLCHOLINESTERASE [J].
DAWSON, RM .
NEUROSCIENCE LETTERS, 1989, 100 (1-3) :227-230
[5]   ASSESSMENT OF THE COMPETITION BETWEEN TACRINE AND GALLAMINE FOR BINDING-SITES ON ACETYLCHOLINESTERASE [J].
DAWSON, RM ;
DOWLING, MH ;
PORETSKI, M .
NEUROCHEMISTRY INTERNATIONAL, 1991, 19 (1-2) :125-133
[6]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&
[7]   KINETICS FOR THE INHIBITION OF ACETYLCHOLINESTERASE FROM THE ELECTRIC-EEL BY SOME ORGANOPHOSPHATES AND CARBAMATES [J].
FORSBERG, A ;
PUU, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 140 (01) :153-156
[8]   PROTECTION AGAINST DIISOPROPYLFLUOROPHOSPHATE INTOXICATION BY MEPTAZINOL [J].
GALLI, A ;
MAZRI, A .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 95 (03) :388-396
[9]   EFFECT OF RANITIDINE ON ILEAL MYENTERIC PLEXUS PREPARATION AND ON ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE [J].
GALLI, A ;
MANTOVANI, P ;
PEPEU, G .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (12) :1845-1850
[10]   INVITRO AND INVIVO PROTECTION OF ACETYLCHOLINESTERASE BY ESEROLINE AGAINST INACTIVATION BY DIISOPROPYL FLUOROPHOSPHATE AND CARBAMATES [J].
GALLI, A ;
AIELLO, PM ;
RENZI, G ;
BARTOLINI, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (01) :42-48